Satellite Symposium:
Optimizing Outcomes in Invasive Fungal Disease (Not Official IDWeek Programming - Supported by independent educational grants from Astellas; Merck & Co, Inc; Gilead Sciences Europe, Ltd.; T2 Biosystems; MiraVista Diagnostics; and Viracor-IBT Laboratories - See Affiliated Events Guide)
Tuesday, October 6, 2015: 6:00 PM-8:00 PM
Room: 29--ABCD

Learning Objectives:

All Satellite Symposia, Presentation Theaters, and Learning Lounges preceding and following the Official Program IDWeekTM 2015 are independently organized and executed.  IDWeek does not endorse or support the programming of any Symposium, Presentation Theater or Learning Lounge.

Faculty:

Luis Ostrosky-Zeichner, MD, FACP, FIDSA, FSHEA (chair)

Professor of Medicine and Epidemiology

UT Health Medical School

Medical Director of Epidemiology

Memorial Hermann Texas Medical Center

Houston, Texas

 

Melissa D. Johnson, PharmD

Associate Professor of Medicine

Division of Infectious Diseases and International Health

Duke University Medical Center

Durham, North Carolina

 

Dimitrios P. Kontoyiannis, MD, ScD, FACP, FIDSA

Frances King Black Endowed Professor, Infectious Diseases

Deputy Head, Division of Internal Medicine 

Department of Infectious Diseases

The University of Texas MD Anderson Cancer Center

Adjunct Professor, Baylor College of Medicine

Adjunct Professor, University of Houston

Houston, Texas          

 

Thomas F. Patterson, MD, FACP

Professor of Medicine and Chief, Division of Infectious Diseases

University of Texas Health Science Center

Director, San Antonio Center for Medical Mycology

San Antonio, Texas

 

Program Objectives:

At the conclusion of the program, participants will be able to:

  • Compare available and emerging therapies and diagnostics for management of IFD
  • Address pharmacologic considerations in optimal use of therapies for IFD
  • Select appropriate evidence-based antifungal diagnostics and therapies based on specific patient characteristics
  • Incorporate an interdisciplinary approach to the management of IFD, with the goal of improved antifungal stewardship
  • Provide accurate and appropriate counsel as part of the treatment team


Accreditation Statement—The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Nebraska Medical Center, Center for Continuing Education designates this live activity for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Postgraduate Institute for Medicine designates this continuing education activity for 2 contact hours (0.2 CEUs) of the Accreditation Council for Pharmacy Education (Universal Activity Number - 0809-9999-15-248-L01). Type of Activity: Application

Agenda subject to change and was provided by:

Terranova Medica, LLC, 1257 Buena Vista Street, Ventura, CA; Phone/Fax: 1-877-276-4523;tdavis@terranovamedica.com. Register now at IDWEEK2015.FungusCME.org. Please contact TOM DAVIS directly at 1-714-724-1127 or TDAVIS@TERRANOVAMEDICA.COM for more information.

Target Audience: Infectious diseases physicians

CME Credits:

ACPE Credits:

ACPE Number:


See more of: Satellite Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.